Pure Global AI
ANVISA registration 81733730021Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 81733730021TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDATRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECHRisk Class II
Verified
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
View exact technical-name matches →
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Família Premier Hb9210 Coluna Analítica HbA1c
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
81733730021
Process Number
25351043776202521
CNPJ
15648426000204
Company information
Registration Holder
TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA
Manufacturer
TRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECH
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
May 05, 2025
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81733730021 and manufactured by TRINITY BIOTECH PRIMUS CORPORATION DBA TRINITY BIOTECH. The registration is held by TRINITY BIOTECH DO BRASIL COMERCIO E IMPORTACAO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.